Scanning laser Doppler may predict disease progression of localised scleroderma in children and young adults.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Works matching IS 02613360 AND DT 2013 AND VI 32 AND IP 2
Results: 32
1
2
Neutrophil counts distinguish between malignancy and arthritis in children with musculoskeletal pain: a case-control study.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
3
Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
4
Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
5
Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
6
Relationship between inflammatory markers, oxidant-antioxidant status and intima-media thickness in prepubertal children with juvenile idiopathic arthritis.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
7
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
8
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
9
Magnetic resonance imaging of the sacroiliac joints in the early detection of spondyloarthritis: no added value of gadolinium compared with short tau inversion recovery sequence.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
10
Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
11
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the Autoimmune and Rituximab registry.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
12
Camptodactyly-arthropathy-coxavara-pericarditis syndrome in Saudi Arabia: clinical and molecular genetic findings in 22 patients.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
13
Glucocorticoid-related changes in body mass index among children and adolescents with rheumatic diseases.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
14
Adding to complexity: comorbidity in paediatric rheumatic disease.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
15
Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a Phase IIb, randomised, double-blind, placebo-controlled, multicentre study.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
16
High-sensitivity C-reactive protein, disease activity, and cardiovascular risk factors in systemic lupus erythematosus.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
17
Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
18
Lymphoma risk in systemic lupus: effects of disease activity versus treatment.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
19
Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
20
Progression of nailfold microvascular damage and antinuclear antibody pattern in systemic sclerosis.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
21
Very early versus early disease: the evolving definition of the "many faces" of systemic sclerosis.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
22
European registry of babies born to mothers with antiphospholipid syndrome.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
23
Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
24
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
25
Rituximab dissociates the tight link between disease activity and joint damage in rheumatoid arthritis patients.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
26
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: findings of a Phase IIIb, multinational, prospective, randomized study.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
27
Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
28
MRI of hand and foot joints of patients with anticitrullinated peptide antibody positive arthralgia without clinical arthritis.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
29
Efficacy of the switch to modified-release prednisone in rheumatoid arthritis patients treated with standard glucocorticoids.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
30
A prediction rule for the development of arthritis in seropositive arthralgia patients.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
31
Evaluation and Treatment of Enthesitis-Related Arthritis.
- Published in:
- Current Medical Literature: Rheumatology, 2013, v. 32, n. 2, p. 33
- By:
- Publication type:
- Article
32
Foreword.
- Published in:
- Current Medical Literature: Rheumatology, 2013, v. 32, n. 2, p. 32
- By:
- Publication type:
- Article